Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Patrick K. Reville"'
Autor:
Courtney D. DiNardo, Maro Ohanian, Zeev Estrov, Patrick K. Reville, Prithviraj Bose, Sa A. Wang, Michael Andreeff, Farhad Ravandi, Musa Yilmaz, Naval Daver, Lucia Masarova, Hagop M. Kantarjian, Tapan M. Kadia, Yesid Alvarado, Guillermo Garcia-Manero, Nicholas J. Short, Rebecca S. S. Tidwell, Guillermo Montalban-Bravo, Nitin Jain, Gautam Borthakur, Elias Jabbour, Steven M. Kornblau, Marina Konopleva
Publikováno v:
Blood. 136:7-9
Background Addition of the BCL2 inhibitor venetoclax to lower intensity therapy improved survival (OS) for older and unfit patients with newly diagnosed AML. We have previously reported the safety and efficacy of the nucleoside analogue cladribine co
Autor:
Ruiping Wang, Zoe Alaniz, Praveen Barrodia, Courtney D. DiNardo, Guillermo Garcia-Manero, Latasha Little, Michael R. Green, Koichi Takahashi, Gheath Alatrash, Wei Wang, Dapeng Hao, P. Andrew Futreal, Jairo Matthews, Jin S. Im, Farhad Ravandi, Steven M. Kornblau, Kunal Rai, Feng Wang, Maomao Ding, Linghua Wang, Jing Ning, Jianhua Zhang, Gautam Borthakur, Patrick K. Reville, James P. Allison, Naval Daver, Padmanee Sharma, Hussein A. Abbas, Marina Konopleva, Katarzyna Tomczak, Tapan M. Kadia, Sreyashi Basu
Publikováno v:
Blood. 136:29-31
Background The success of allogenic stem cell transplantation in curing AML suggests that the immune system can be harnessed to eradicate AML. In a phase 2 trial (NCT02397720) in relapsed/refractory (R/R) AML patients, we demonstrated that the azacit
Autor:
Hussein A. Abbas, Patrick K. Reville, Xianli Jiang, Hui Yang, Alexandre Reuben, Jin Seon Im, Latasha Little, Jefferson C. Sinson, Ken Chen, Andrew Futreal, Guillermo Garcia-Manero
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Aberrant T-cell function is implicated in the pathogenesis of myelodysplastic syndrome (MDS). Monitoring the T-cell receptor (TCR) repertoire can provide insights into T-cell adaptive immunity. Previous studies found skewed TCR repertoires in MDS com
Autor:
Elias Jabbour, Koichi Takahashi, Kapil N. Bhalla, Guillermo Garcia-Manero, Rashmi Malla, Naval Daver, Caitlin R. Rausch, Naveen Pemmaraju, Nitin Jain, Farhad Ravandi, Uday R. Popat, Marina Konopleva, Patrick K. Reville, Michael Andreeff, Hagop M. Kantarjian, Maro Ohanian, Guillermo Montalban-Bravo, Gautam Borthakur, Kelly Marek, Nicholas J. Short, Koji Sasaki, Alessandra Ferrajoli, Ghayas C. Issa, Tapan M. Kadia, Mark Brandt, Courtney D. DiNardo
Publikováno v:
Blood. 138:367-367
Background The combination of venetoclax and 5-azacytidine (5-AZA) for older and unfit patients with newly diagnosed AML has led to significant improvements in remission rates and survival compared to 5-AZA alone. We previously reported encouraging r
Autor:
Patrick K. Reville, Zeev Estrov, Sherry Pierce, Srdan Verstovsek, Michael Andreeff, Alessandra Ferrajoli, Naveen Pemmaraju, Tapan M. Kadia, Elias Jabbour, Farhad Ravandi, Marina Konopleva, Koji Sasaki, Maro Ohanian, Guillermo Garcia-Manero, Courtney D. DiNardo, Hagop M. Kantarjian, Graciela M. Nogueras González, Gautam Borthakur, Nitin Jain, Naval Daver
Publikováno v:
Blood. 136:44-45
Background Recent advances have led to higher response rates and improved survival in patients with newly diagnosed AML. However, early death, lack of response, and long term leukemia-free survival remain important challenges. Early mortality in AML
Autor:
Tapan M. Kadia, Maro Ohanian, Elias Jabbour, Farhad Ravandi, Courtney D. DiNardo, Michael Andreeff, Gautam Borthakur, Carlos E. Bueso-Ramos, Koji Sasaki, Hussein A. Abbas, Guillermo Garcia-Manero, Sherry Pierce, Marina Konopleva, Patrick K. Reville, Hagop M. Kantarjian, Nicholas J. Short, Naval Daver, Alexis Geppner
Publikováno v:
Blood. 136:25-26
Background Myeloid sarcoma (MS) is a rare extramedullary presentation of acute myeloid leukemia (AML). While MS in the setting of concomitant medullary acute myeloid leukemia (AML) is relatively well described, much less is known about patients prese
Autor:
Elisabeth Paietta, Fangxin Hong, Brad S. Kahl, Kyung Mann Kim, Vaishalee P. Kenkre, Bartosz Grzywacz, Erik A. Ranheim, Patrick K. Reville, Lakeesha Carmichael, Eneida A. Mendonça, Amy K. Erbe, Wei Wang, Paul M. Sondel, Sandra J. Horning, Anna Hoefges, Yiqiang Song, Songwon Seo, Jeffrey S. Miller, Randy D. Gascoyne, Jacquelyn A. Hank
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Background The ECOG-ACRIN Cancer Research Group evaluated rituximab treatment schedules for patients with newly-diagnosed low-tumor-burden follicular-lymphoma (FL). All patients received 4-weekly rituximab treatments as induction therapy. Clinically-
Autor:
Susan L. Cohn, Stephen D. Gillies, Ralph A. Reisfeld, Julie R. Park, Wei Wang, Alice L. Yu, M. Fevzi Ozkaynak, Patrick K. Reville, Jacquelyn A. Hank, Michael D. Hogarty, Wendy B. London, Andrew L. Gilman, Paul M. Sondel, Yiqiang Song, Arlene Naranjo, Lakeesha Carmichael, Mitchell B. Diccianni, Amy K. Erbe, John M. Maris, Katherine K. Matthay, Dustin Hess, KyungMann Kim, Eneida A. Mendonça
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 24, iss 1
Purpose: In 2010, a Children's Oncology Group (COG) phase III randomized trial for patients with high-risk neuroblastoma (ANBL0032) demonstrated improved event-free survival (EFS) and overall survival (OS) following treatment with an immunotherapy re
Autor:
Amy K. Erbe, Wei Wang, Patrick K. Reville, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonca, Yiqiang Song, Jacquelyn A. Hank, Wendy B. London, Arlene Naranjo, Fangxin Hong, Michael D. Hogarty, John M. Maris, Julie R. Park, M. F. Ozkaynak, Jeffrey S. Miller, Andrew L. Gilman, Brad Kahl, Alice L. Yu, Paul M. Sondel
Publikováno v:
Frontiers in Immunology
Frontiers in immunology, vol 8, iss JUN
Frontiers in Immunology, Vol 8 (2017)
Frontiers in immunology, vol 8, iss JUN
Frontiers in Immunology, Vol 8 (2017)
Killer-cell immunoglobulin-like receptors (KIRs) are a family of glycoproteins expressed primarily on natural killer cells that can regulate their function. Inhibitory KIRs recognize MHC class I molecules (KIR-ligands) as ligands. We have reported as
Autor:
Gonzalo V. Gonzalez-Stawinski, William M. Baldwin, Amy S. Nowacki, Lynne Klingman, Aiwen Zhang, David O. Taylor, Medhat Askar, Eileen Hsich, Nicholas G. Smedira, Randall C. Starling, Suzanne Bakdash, Jenna Daghstani, Nader Moazami, Patrick K. Reville
Publikováno v:
The Journal of Heart and Lung Transplantation. 32:1241-1248
Ventricular assist devices (VADs) are increasingly being used as a bridge to transplantation and have been implicated as a risk factor for allosensitization to human leukocyte antigens (HLA). We investigate the association between VAD and allosensiti